Understanding insurance coverage for TMS therapy
If you are exploring insurance coverage for TMS therapy, you are likely already living with major depressive disorder that has not responded to several antidepressants. You might be weighing TMS vs antidepressants, or searching for a non medication treatment for depression that still has strong scientific support. Understanding how insurers think about TMS, what they require, and what your out‑of‑pocket costs might be can help you move forward with more confidence.
Transcranial magnetic stimulation, including NeuroStar TMS, is an FDA‑approved brain stimulation therapy for depression. It is considered a medically necessary treatment for certain patients with treatment‑resistant depression. Most commercial insurers and Medicare do cover TMS when clear criteria are met, but approval is not automatic. You usually need documented evidence that you have tried and not benefited enough from standard treatments first.
When insurance typically covers TMS
Insurance plans structure coverage for TMS around a clinical picture often described as treatment‑resistant depression. If you meet that definition and do not have safety contraindications, there is a good chance your plan will at least consider authorization.
Common clinical criteria
While each insurer writes its own policy, many follow a similar framework to what is used by Medicare and larger commercial plans:
- A DSM‑5 diagnosis of major depressive disorder, often moderate to severe
- Inadequate response to at least 2 to 4 antidepressant medication trials at adequate dose and duration
- A trial of evidence‑based psychotherapy with a licensed clinician
- Age 18 or older
- No contraindications such as certain implanted metallic devices
In California, for example, most health plans cover TMS for major depressive disorder and obsessive compulsive disorder if you have a qualifying diagnosis, failed 2 to 4 antidepressants, and completed a psychotherapy trial [1]. These requirements are similar across many regions.
If your depression has not improved despite multiple medications, you likely fit the profile of depression not responding to medication that insurers focus on when they consider TMS as a next‑step treatment.
Medicare coverage basics
Medicare only covers transcranial magnetic stimulation for adults with severe major depressive disorder when a physician determines the treatment is medically necessary [2]. Novitas, one of the Medicare contractors, specifies that TMS for severe MDD is considered medically reasonable and necessary for up to six weeks under defined criteria and does not consider use for OCD medically necessary at this time [3].
Key Medicare details include:
- Coverage is usually under Part B as an outpatient service
- Part B in 2025 includes a monthly premium, a yearly deductible, and 20% coinsurance on covered services [2]
- TMS sessions are typically covered for up to six weeks when criteria are met
- Medicare Advantage (Part C) plans must at least match Original Medicare coverage, though copays and deductibles can vary by plan and location [2]
Medicare will not cover TMS if you have contraindications or safety concerns that make the procedure unsuitable for treating severe MDD [2]. Your TMS provider and psychiatrist will review this with you before treatment.
How insurers define treatment‑resistant depression
Since TMS is positioned as an advanced option, insurers require clear documentation that you have not responded adequately to more standard care. This pattern is often referred to as treatment‑resistant depression.
Typical definition and documentation
Across many policies, treatment‑resistant depression often means:
- You have a diagnosis of major depressive disorder
- You have tried 2 to 4 antidepressant medications, usually from different classes
- Each medication trial was at a therapeutic dose for a sufficient duration
- You still have significant depressive symptoms that impair your functioning
Some insurers are even more specific. For example, some Optum plans require four antidepressant trials during the current depressive episode before approving TMS coverage [4]. Many plans also expect a record of at least one course of structured psychotherapy.
If this description fits you, you may benefit from a dedicated treatment resistant depression program that can coordinate medications, psychiatrist supervised TMS therapy, and psychotherapy.
Why TMS is considered an advanced treatment
TMS is not usually the first line treatment for depression. For many people, standard antidepressants and therapy are effective, so insurers focus TMS coverage on those who have already tried those paths.
As part of a broader set of advanced depression treatment options, NeuroStar TMS is a noninvasive, outpatient brain stimulation therapy for depression. Insurers see it as appropriate when:
- Ongoing symptoms remain despite multiple medication trials
- Side effects make further medication changes difficult
- You are seeking a non‑systemic or adjunctive option that targets brain circuits more directly
Aligning your clinical story with this framework makes it easier for your care team to demonstrate medical necessity in the prior authorization process.
What types of TMS insurance usually covers
There are several TMS variants and protocols. Insurance coverage focuses primarily on conventional, evidence‑based approaches that have strong data for major depressive disorder.
Conventional rTMS and Deep TMS
In the United States, conventional repetitive TMS, often delivered with systems like NeuroStar, is the most widely covered form of TMS. As of 2024, it is the standard TMS type reimbursed by insurers, with total treatment costs without insurance typically ranging from about 6,000 to 15,000 dollars for a full course, and out‑of‑pocket costs with coverage often 50 to 250 dollars per session depending on the plan [5].
Deep TMS, which uses a different coil design to reach deeper brain structures, is also commonly covered for major depressive disorder and anxious depression. It is currently the only TMS modality covered by many insurers for OCD, with patient costs similar to conventional rTMS when insurance is in place [5].
Accelerated and experimental protocols
Some newer protocols, such as intermittent Theta‑Burst Stimulation and accelerated treatments like SAINT TMS, have emerging evidence but more limited insurance coverage. Most insurance plans do not cover these accelerated approaches in outpatient settings. SAINT, for example, is reimbursed by Medicare and Medicaid only when provided in hospital settings, and outpatient costs can range from about 30,000 to 36,000 dollars for a one‑week program [5].
If you are primarily interested in coverage, conventional NeuroStar‑type rTMS is usually the most practical and accessible path.
Typical costs of TMS with and without insurance
Understanding both the full cost of care and your likely share helps you plan for treatment and avoid surprises.
Without insurance coverage, a standard course of TMS, usually around 30 to 36 sessions, often ranges from 7,000 to 10,000 dollars, with each session priced around 200 to 300 dollars [1]. Several sources report total course costs between 6,000 and 15,000 dollars, depending on the number of sessions and specific clinic fees [6].
When insurance is in place:
- Many patients pay little or no out‑of‑pocket for covered TMS, aside from copays and deductibles
- For those with coinsurance, per‑session costs often fall between 50 and 250 dollars, depending on the plan [6]
- Medicare Part B typically requires you to meet your deductible and then pay 20% of the approved amount for each covered service [2]
If you are considering a specialized or accelerated protocol that is not covered, you should expect significantly higher cash‑pay costs, which can be comparable to or higher than the full, uninsured price of conventional TMS.
While headline numbers can feel overwhelming, many patients ultimately pay much less because their insurance covers the majority of the TMS course once medical necessity is approved.
How the prior authorization process works
For almost every plan, TMS requires prior authorization. This is the process in which your insurer reviews your case to decide whether they will cover treatment before you start.
What insurers request
Prior authorization usually involves your TMS provider submitting a detailed packet to your insurance company. According to Solstice Training Institute, insurers may request [4]:
- Your diagnosis and documentation that it meets their covered indications
- A treatment plan, including TMS protocol, frequency, and duration
- Medical records that show prior antidepressant trials, including doses and durations
- Documentation of psychotherapy attempts
- A safety screening and attestation that you do not have contraindications
- Notes from your psychiatrist explaining why TMS is medically necessary now
Some insurers strictly enforce their criteria. If your diagnosis is not on the approved list, or if you have not met the required number of failed medication trials, coverage may be limited or denied [4].
Why you should obtain authorization before starting
Starting TMS before authorization can create significant financial risk. If your insurer later denies coverage, obtaining retroactive approval is often challenging, and you may be responsible for the full cost [4].
Good TMS programs are familiar with these processes. Many, similar to Axis Integrated Mental Health, work directly with insurers to secure authorization before treatment and provide financial consultations to explain copays, deductibles, and coinsurance so that you understand your potential costs in advance [7].
When insurance may deny or limit coverage
Even if you believe you are a strong candidate, there are situations in which insurance companies may decline TMS authorization or restrict coverage.
Common reasons for denial
Based on current policies and clinical experience, insurers may deny TMS coverage if:
- Your diagnosis is not one of the covered conditions, for example, some plans do not yet cover TMS for OCD or milder depression [3]
- You have not completed the required number of antidepressant trials or psychotherapy attempts
- Documentation is incomplete or does not clearly show treatment resistance
- You have contraindications that raise safety concerns [8]
Sometimes a denial reflects missing information rather than a true lack of eligibility. In those cases, your provider can often supply additional records or clarify details.
How to respond to a denial
If your insurance denies coverage for TMS, you are not necessarily at a dead end. Salience Neuro recommends that you:
- Contact your insurer to understand the exact reason for denial
- Work with your psychiatrist or TMS provider to appeal, including more detailed documentation of medical necessity
- Ask your care team if there are other plan‑specific forms or assessments that could strengthen your case [9]
Appeals take time, but many patients eventually obtain coverage once eligibility criteria are clearly demonstrated.
How TMS fits into your broader treatment plan
Insurance coverage is important, but so is understanding how TMS will be integrated with your ongoing psychiatric and psychotherapeutic care.
Psychiatrist supervision and safety
TMS should be overseen by clinicians who are trained in neuromodulation and in the treatment of complex mood disorders. In a psychiatrist supervised TMS therapy setting, your psychiatrist is responsible for:
- Confirming your diagnosis and TMS eligibility
- Determining stimulation parameters and adjusting them as needed
- Monitoring for side effects or changes in mood, including early signs of improvement or distress
- Coordinating any medication adjustments during your TMS course
Medicare specifically requires that TMS services be performed within the provider’s licensure scope and state laws, and that properly trained professionals submit claims that meet coverage criteria [3]. This standard is important regardless of your insurance type.
Combining TMS with psychotherapy
TMS targets brain circuits involved in mood regulation, while psychotherapy helps you build new coping skills, address patterns in relationships, and reshape how you respond to stressors. Many programs now offer an integrated TMS and psychotherapy program so that you can:
- Practice new skills while your brain circuits are responding to stimulation
- Address long‑standing cognitive and emotional patterns that contribute to depression
- Create a more durable change that lasts beyond the TMS course
Some advanced centers also combine TMS with cognitive behavioral therapy during the same treatment period, which may improve response and remission rates compared to TMS alone [5].
What to expect from TMS outcomes and coverage over time
When you pursue TMS through insurance, you are committing to both a clinical treatment course and a structured utilization review process. It helps to understand how both unfold.
Clinical expectations and response
TMS is not a quick fix, but it is a well‑studied option for people who have already tried multiple antidepressants. Sessions are typically delivered daily on weekdays over several weeks, and many people begin to notice changes in energy, sleep, or mood as the course progresses.
To learn more about effectiveness, you can explore resources such as how effective is TMS for depression and TMS therapy success rate. These can help you set realistic goals and understand how TMS compares to additional medication trials.
Insurance review during and after treatment
Some insurers periodically review TMS claims to verify that treatment remains medically necessary, especially if you or your provider request additional sessions beyond the standard acute course. Medicare, for instance, notes that TMS claims can be subject to post‑payment data analysis and medical review audits to ensure compliance with coverage criteria [3].
In recent years, some commercial plans have also begun to cover a second course of TMS when symptoms return and the first course was clearly beneficial [1]. Coverage is not guaranteed, but your response to the first course and your ongoing clinical picture are central to these decisions.
Taking your next step
If you are considering TMS because your depression has not responded to medications, you are not alone. Many people in your position are now finding meaningful relief through tms therapy for major depressive disorder, particularly with established systems like Neurostar TMS therapy.
A practical way to move forward is to:
- Confirm with a psychiatrist that you meet typical TMS therapy eligibility criteria for treatment‑resistant depression.
- Ask your TMS clinic to verify your insurance benefits and begin the prior authorization process before your first session.
- Explore how TMS will be combined with ongoing psychotherapy and medication management as part of a comprehensive tms for treatment resistant depression plan.
With clear medical documentation and support from a team experienced in neuromodulation and insurance navigation, you can make informed decisions about TMS as part of a broader strategy to address your depression more effectively.
